Arthritis Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint (2013)

    This study shows that cannabinoid receptors 2 (CB2) inhibit and contribute to pain relief from the prevalent joint disease, called osteoarthritis (OA). The data provided by this study provide new clinically relevant evidence that joint damage and spinal CB2 receptor expression are correlated in combination with convergent preclinical evidence that activation of CB2 receptors inhibits central sensitization and its contribution to the manifestation of chronic pain of the (OA). View study

  • Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (2014)

    This research was done on the therapeutic effect of cannabinoid selective CB2 receptor agonist on arthritis. This study was able to conclude that a selective CB2 agonist can inhibit the production of inflammatory mediators of FLS and osteoclastogenesis, it could be for this reason a new therapy for rheumatoid arthritis (RA) View study

  • Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1b induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes (2013)

    In this study we try to determine how cannabinoid mesylate WIN-55,212-2 inhibits matrix metalloproteinase is activated by interleukin-1b and the tissue inhibitor of matrix metalloproteinase expression in human chondrocytes. The results show that the actions of WIN-55 suggest a mechanism by which cannabinoids can act to prevent the breakdown of cartilage in arthritis. View study

  • Characterisation of the Cannabinoid Receptor System in Synovial Tissue and Fluid in Patients With Osteoarthritis and Rheumatoid Arthritis (2007)

    This research showed that cannabinoids (CB1) and (CB2) and cannabis-based drugs have a therapeutic potential in inflammatory diseases, including rheumatoid arthritis (RA) and osteortritis (OA). The final data indicate that the receptor system present in the synovium of the joints can be a therapeutic target for the treatment of inflammation and pain related to (OA) and (RA). View study